sequella.com

Sequella Overview

Sequella Acquires Exclusive Worldwide Rights to Pfizer's Sutezolid, Currently in Clinical Development for Tuberculosis. Sequella's Lead Antitubercular Drug Candidate SQ109 Begins Phase 2b Clinical Trial in Africa. Maxwell Biotech Venture Fund’s Portfolio Company, Infectex, Enrolls First Multi-Drug Resistant Tuberculosis (MDR-TB) Patients in Pivotal Clinical Trial of SQ109, Licensed from Sequella. Sequella is a clinical stage antiinfectives company focused on discovering, developing, and commercializing i...

http://www.sequella.com/

OVERVIEW OF sequella.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

6

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR SEQUELLA.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

June

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Monday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 4.9 out of 5 with 7 reviews

5 star

6

4 star

1

3 star

0

2 star

0

1 star

0

Hey there! Start your review of sequella.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

0.2 seconds

CONTACTS AT SEQUELLA.COM

Sequella

9610 Medical●●●●●●●●●●●●e, Suite 200

Roc●●●lle , MD, 20850

US

1.30●●●●7776

1.99●●●●9999

ka●●●●●●●●●●●●●●●●●@SEQUELLA.COM

View this contact

Sequella

Horwith, Gary

9610 Me●●●●●●●nter Dr

Roc●●●lle , MD, 20850

US

301.●●●●7776

301.●●●●7778

ga●●●●●●●●●@sequella.com

View this contact

Stickdog Telecom, Inc.

Stickdog Telecom, Inc.

143A ●●●●●CH ST

VI●●NA , VA, 22180

US

1.70●●●●1500

dn●●●●●●@STICKDOG.COM

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 1997 December 05
UPDATED: 2011 August 15
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

27

YEARS
5

MONTHS
7

DAYS

NAME SERVERS

1: ns43.worldnic.com
2: ns44.worldnic.com

REGISTRAR

NETWORK SOLUTIONS, LLC.

WHOIS : whois.networksolutions.com

REFERRED : http://networksolutions.com

CONTENT

PAGES IN
THIS WEBSITE

6

SSL

EXTERNAL LINKS

10

SITE IP

206.188.192.194

LOAD TIME

0.156 sec

SCORE

6.2

PAGE TITLE

Sequella Overview | sequella.com Reviews

<META> DESCRIPTION

Sequella Acquires Exclusive Worldwide Rights to Pfizer's Sutezolid, Currently in Clinical Development for Tuberculosis. Sequella's Lead Antitubercular Drug Candidate SQ109 Begins Phase 2b Clinical Trial in Africa. Maxwell Biotech Venture Fund’s Portfolio Company, Infectex, Enrolls First Multi-Drug Resistant Tuberculosis (MDR-TB) Patients in Pivotal Clinical Trial of SQ109, Licensed from Sequella. Sequella is a clinical stage antiinfectives company focused on discovering, developing, and commercializing i...

<META> KEYWORDS

1 company overview

2 science

3 product pipeline

4 media center

5 latest news

6 release

7 welcome to sequella

8 mycobacterium tuberculosis

9 infections

10 helicobacter pylori

CONTENT

Page content here

KEYWORDS ON PAGE

company overview,science,product pipeline,media center,latest news,release,welcome to sequella,mycobacterium tuberculosis,infections,helicobacter pylori,clostridium difficile,m avium paratuberculosis,mail@sequella com,site map

SERVER

Apache/2.2.29 (Unix) FrontPage/5.0.2.2635

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Sequella Overview | sequella.com Reviews

https://sequella.com

Sequella Acquires Exclusive Worldwide Rights to Pfizer's Sutezolid, Currently in Clinical Development for Tuberculosis. Sequella's Lead Antitubercular Drug Candidate SQ109 Begins Phase 2b Clinical Trial in Africa. Maxwell Biotech Venture Fund’s Portfolio Company, Infectex, Enrolls First Multi-Drug Resistant Tuberculosis (MDR-TB) Patients in Pivotal Clinical Trial of SQ109, Licensed from Sequella. Sequella is a clinical stage antiinfectives company focused on discovering, developing, and commercializing i...

INTERNAL PAGES

sequella.com

1

Science

http://www.sequella.com/science/index.html

It is projected that as many as 70 million people could die of tuberculosis over the next 3 decades. The Company's long-term vision is to radically improve treatment of. A variety of infectious diseases with efficacious new antibiotics that each have a novel mechanism of action. Our small molecule product candidates act on multiple and different cellular pathways and have broad market potential, with applications in mycobacterial diseases, fungal infections, pneumonias, and other diseases with known ...

2

Sequella Overview

http://www.sequella.com/index.html

Sequella Acquires Exclusive Worldwide Rights to Pfizer's Sutezolid, Currently in Clinical Development for Tuberculosis. Sequella's Lead Antitubercular Drug Candidate SQ109 Begins Phase 2b Clinical Trial in Africa. Maxwell Biotech Venture Fund’s Portfolio Company, Infectex, Enrolls First Multi-Drug Resistant Tuberculosis (MDR-TB) Patients in Pivotal Clinical Trial of SQ109, Licensed from Sequella. Sequella is a clinical stage antiinfectives company focused on discovering, developing, and commercializing i...

3

Sequella Overview

http://www.sequella.com/overview/index.html

30 million people died of tuberculosis between 1990-1999. Our growth strategy capitalizes on our experience to advance new compounds with best-in-class potential from the bench to the clinic - ultimately delivering these products to patients through strategic partnerships and alliances. Please see our Executive Summary. For more information on the company and our products. 9610 Medical Center Drive, Suite 200 Rockville, MD 20850 Ph: 301-762-7776 Fax: 301-762-7778. 2013 Sequella, Inc.

4

Media

http://www.sequella.com/media/index.html

Four percent of MDR-TB cases in the U.S. met the criteria for XDR-TB. Press Releases and Articles. Select to see press releases and publications that year. Sequella Acquires Exclusive Worldwide Rights to Pfizer's Sutezolid, Currently in Clinical Development for Tuberculosis. Sequella Lead Antitubercular Drug Candidate SQ109 Begins Phase 2b Clinical Trial in Africa. Statement from Dr. Carol Nacy, CEO of Sequella, Regarding World TB Day (March 24, 2013). Sequella Licenses Rights to Commercialize SQ109 for ...

5

Sequella Pipeline

http://www.sequella.com/pipeline/index.html

Product Backgrounders ». SQ109 for H. pylori. SQ641 for C. difficile. 9610 Medical Center Drive, Suite 200 Rockville, MD 20850 Ph: 301-762-7776 Fax: 301-762-7778. 2013 Sequella, Inc.

UPGRADE TO PREMIUM TO VIEW 1 MORE

TOTAL PAGES IN THIS WEBSITE

6

LINKS TO THIS WEBSITE

maxwellbio.com

Новости | Maxwell Biotech Group

http://www.maxwellbio.com/news

Перейти к основному содержанию. 109240 Москва, Россия. Ул Верхняя Радищевская, 12/19, стр.1. 7 495 726 5253. НейроМакс начал клиническое исследование 1 фазы инновационного препарата для лечения нейропатической боли. Основной целью исследования является оценка безопасности и переносимости AQU-005 в различных дозировках при многократном применении, а также изучение фармакокинетики препарата. В исследование планируется включить не менее 24 здоровых добровольцев. Основной целью исследования является оценка б...

perrinhome.com

perrinhome

http://www.perrinhome.com/labels/WTN%20news.html

Authentic takes on science and patent law in Madison and beyond. Saturday, February 6, 2010. Strategy, advice exchanged at Biotech VC Forum. This is the second of three articles I wrote last fall for WTN News. You can read it as originally published here. Forget the recession. Or perhaps, thrive in spite of it. That seemed to be the prevailing mindset at the AllThingsLifeSciences 2009 Venture Capital Forum. And $1 M YTD revenue for A&G Pharmaceutical. After over a year of battered markets and upheavals i...

perrinhome.com

perrinhome

http://www.perrinhome.com/labels/journalism.html

Authentic takes on science and patent law in Madison and beyond. Saturday, February 6, 2010. Strategy, advice exchanged at Biotech VC Forum. This is the second of three articles I wrote last fall for WTN News. You can read it as originally published here. Forget the recession. Or perhaps, thrive in spite of it. That seemed to be the prevailing mindset at the AllThingsLifeSciences 2009 Venture Capital Forum. And $1 M YTD revenue for A&G Pharmaceutical. After over a year of battered markets and upheavals i...

maxwellbiotech.com

News | Maxwell Biotech

http://maxwellbiotech.com/news

Skip to main content. 3, June, 16. Maxwell Biotech Venture Fund’s Portfolio Company Hepatera Announces Publication of Myrcludex B Clinical Results in Journal of Hepatology. Hepatera LLC and it`s development partner MYR GmbH today announced that the results of the first-in-man Phase 1 study in healthy volunteers, and the proof-of-concept Phase 2a study in HBV/HDV co-infected patients were published as two separate "back-to-back" articles in Journal of Hepatology and are available online. We are carefully ...

perrinhome.com

perrinhome: Strategy, advice exchanged at Biotech VC Forum

http://www.perrinhome.com/2010/02/strategy-advice-exchanged-at-biotech-vc.html

Authentic takes on science and patent law in Madison and beyond. Saturday, February 6, 2010. Strategy, advice exchanged at Biotech VC Forum. This is the second of three articles I wrote last fall for WTN News. You can read it as originally published here. Forget the recession. Or perhaps, thrive in spite of it. That seemed to be the prevailing mindset at the AllThingsLifeSciences 2009 Venture Capital Forum. And $1 M YTD revenue for A&G Pharmaceutical. After over a year of battered markets and upheavals i...

rswallis.com

My Background

http://www.rswallis.com/Pages/aboutus.aspx

Skip to main content. Robert S Wallis, MD, FIDSA. I am a physician scientist with training in Internal Medicine and Infectious Diseases, and expertise in the development of biologics, vaccines, and small molecules. I hold academic appointments as adjunct Professor at Case Western Reserve University. And Rutgers-New Jersey Medical School. In whole blood culture, has been used extensively in TB drug and vaccine development. It is currently being evaluated in an international TB vaccine biomarker projec...

breastcancerstartupchallenge.com

Teams - Breast Cancer Start-up Challenge

http://www.breastcancerstartupchallenge.com/teams.html

1 Diagnostic from biopsies with software analysis. 2 Immunotherapy Using Modified Self Tumor Cells. 3 Combination of Tissue Reconstruction and Recurrence Prevention. 4 Human monoclonal Antibody Based Cancer Therapies. 5 Immunotherapy Using Granulysin Activated Monocytes. 7 Versatile Delivery Method for Cancer Therapeutics. 8 Genomic Based Diagnostic Assay. 9 Tissue-based Diagnostic Assay. 10 Diagnostic Kit for Therapy Benefit Prediction. News and Past Events. Marc Hurlbert, Ph.D. In this role Carolyn ove...

lungposition.blogspot.com

Lung Diseases: October 2010

http://lungposition.blogspot.com/2010_10_01_archive.html

Asthma,Tuberculosis,Cystic Fibrosis, Non-Small Cell Lung Cancer,Respiratory Tract, Respiratory Distress Syndrome, Chronic Obstructive Pulmonary Disease (COPD), Pneumonia, Status Asthmaticus,Respiratory Syncytial Virus(RSV), Portable Oxygen Concentrator, Home Liquid Oxygen, Emphysema, Pulmonary Arterial Hypertension (PAH). Lung Diseases Cies Search Engine [selected websites]. Sequella : International Support for Phase 2 Clini. ImmuneWorks : National Clinical Trial for New Idi. Oct 26, 2010. And a €3...

UPGRADE TO PREMIUM TO VIEW 2 MORE

TOTAL LINKS TO THIS WEBSITE

10

OTHER SITES

sequell.deviantart.com

sequell (sequell) - DeviantArt

Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')" class="mi". Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')". Join DeviantArt for FREE. Forgot Password or Username? Deviant for 5 Years. This deviant's full pageview. Last Visit: 281 weeks ago. This is the place where you can personalize your profile!

sequell.nl

Sequell - maak uw bedrijf overdrachtsklaarSequell

Behoud van één miljard aan ondernemerskapitaal in 10 jaar voor Nederland. Sequell’s Onderscheidend vermogen. 8220;Steeds meer ondernemingen komen beschikbaar voor overname”. De vergrijzing onder ondernemers, maakt dat steeds meer ondernemingen op de markt komen voor overname. Daarnaast zijn er ondernemingen die klaarliggen voor bedrijfsovername doordat:. Ander soort leiderschap nodig is voor continuering. De focus van de ondernemer zich heeft verlegd geen geschikte opvolger voorhanden is.

sequella.blogspot.com

sequella

Subscribe to: Posts (Atom). View my complete profile. Watermark template. Powered by Blogger.

sequella.co.uk

Sequella - Jeff Higgott photography

Http:/ www.sequella.co.uk. Sequella.co.uk - the home of Jeff Higgott, a freelance photographer based in East Anglia, UK. Jeff has a large potfolio of high quality digital images available to publishers, specialising in:. Jeff's photographs have been published widely in books, magazines and journals. A selection of Jeff's photos can be seen by following the above links on this page, or for a wider general selection see Jeff's Flickr pages. Mildenhall Fen Tigers vs. Berwick Bandits.

sequella.com

Sequella Overview

Sequella Acquires Exclusive Worldwide Rights to Pfizer's Sutezolid, Currently in Clinical Development for Tuberculosis. Sequella's Lead Antitubercular Drug Candidate SQ109 Begins Phase 2b Clinical Trial in Africa. Maxwell Biotech Venture Fund’s Portfolio Company, Infectex, Enrolls First Multi-Drug Resistant Tuberculosis (MDR-TB) Patients in Pivotal Clinical Trial of SQ109, Licensed from Sequella. Sequella is a clinical stage antiinfectives company focused on discovering, developing, and commercializing i...

sequellabs.com

Welcome to AVRO Computing Inc.

Welcome to Avro Computing. We provide data expertise and advanced software architected to leverage a company’s large operational, incompatible data volumes. We assist IT in delivering to business user groups operational data necessary to create a corporate ROI that meets the company’s Financial Hurdle Rate. Why the renewed focus on operational data:. Data have overtaken IT technology. Data have no “Single Version” of the truth – the right data. For more information, go to our Contact. Cupertino, CA 95014.

sequellabs.net

Welcome to AVRO Computing Inc.

Welcome to Avro Computing. We provide data expertise and advanced software architected to leverage a company’s large operational, incompatible data volumes. We assist IT in delivering to business user groups operational data necessary to create a corporate ROI that meets the company’s Financial Hurdle Rate. Why the renewed focus on operational data:. Data have overtaken IT technology. Data have no “Single Version” of the truth – the right data. For more information, go to our Contact. Cupertino, CA 95014.

sequellafoundation.org

visit different websites related to airlines | you can get amazing discounts by liking a certain page

Visit different websites related to airlines. You can get amazing discounts by liking a certain page. US Government Volunteers to Pay for Infringement by Japan Airlines. October 25, 2014. US Government Volunteers to Pay for Infringement by Japan Airlines. The number of international as well as domestic flights has doubled in the last few years. With increasing demand, carriers are. People can make video calls in just a few seconds. Breakthroughs in technological development and its implication are among.

sequellaphoto.blogspot.com

SEQUELLA

sequelle.deviantart.com

sequelle (Stamps & Stocks) - DeviantArt

Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) " class="mi". Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ". Join DeviantArt for FREE. Forgot Password or Username? Account no longer updated]. Where Stamp Makers Unite! Deviant for 7 Years. Where Stamp Makers Unite! This deviant's activity is hidden. Deviant since Jul 14, 2008. Account no longer updated]. Why," you ask?